GlassScriptPhysician profile
Carlo P Honrado
NPI 1437265980
$2,180.62
in general payments reported to CMS, 2019-2025
17 companies · $555 in 2025
The $555 reported for 2025 was more than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $257 · 2021: $109 · 2022: $145 · 2023: $365 · 2024: $311 · 2025: $555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,230.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $348.69 | 2019-2024 | |
| Stryker Corporation | $345.71 | 2019-2025 | Xpress Loprofile, Xpress Ent Dilation System, Scopis Ent |
| Revance Therapeutics, INC. | $336.31 | 2024-2025 | Daxxify |
| Merz North America, INC. | $230.97 | 2019-2025 | Xeomin |
| Abbvie INC. | $146.57 | 2023-2025 | |
| Allergan, INC. | $138.99 | 2020-2022 | |
| Intersect Ent, INC. | $128.42 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $125.20 | 2024-2025 | |
| Galderma Laboratories, L.P. | $87.90 | 2023 | |
| Smith+Nephew, INC. | $66.41 | 2019-2024 | Tula |
| Medtronic, INC. | $64.68 | 2023 | Sinuva, Propel |
| Acclarent, INC | $39.53 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $37.82 | 2019 | |
| Neurent Medical Limited | $23.63 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Baudax Bio INC. | $21.66 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $21.41 | 2024 | Nucala |
| Hikma Pharmaceuticals USA | $16.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlo Honrado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.